Computational studies of the binding modes of CCR1 antagonists

Molecular Simulation

Volumn 38, Issue 12, 2012, Pages 953-960

  Liu, Yuan ^a   Chen, Binhui ^a   Wei, Jing ^a  

^a TIANJIN UNIVERSITY   (China)

Author keywords

binding site; CC chemokine receptor 1; chemokine; homology modelling; molecular docking

Indexed keywords

3D STRUCTURE; BINDING MODES; CHEMOKINE RECEPTORS; CHEMOKINES; CHRONIC INFLAMMATORY DISEASE; COMPUTATIONAL STUDIES; DRUG DESIGN; DRUG DISCOVERY RESEARCHES; HIGH RESOLUTION CRYSTAL STRUCTURE; HOMOLOGY MODELLING; HYDROPHOBIC INTERACTIONS; HYDROPHOBIC SITES; LIGAND BINDING; MOLECULAR DOCKING; RATIONAL MODELS;

BINDING ENERGY; CRYSTAL STRUCTURE; HYDROPHOBICITY; MOLECULAR MODELING;

BINDING SITES;

EID: 84866691792     PISSN: 08927022     EISSN: 10290435     Source Type: Journal    
DOI: 10.1080/08927022.2012.679617     Document Type: Article

References (38)

1. M. Baggiolini, Chemokines and leukocyte traffic, Nature 392 (1998), pp. 565-568.
2. R.M. Strieter, T.J. Standiford, G.B. Huffnagle, L.M. Colletti, N.W. Lukacs and S.L. Kunkel, "The good, the bad and the ugly." The role of chemokines in models of human disease commentary, J. Immunol. 156 (1996), pp. 3583-3586.
3. P.M. Murphy, M. Baggiolini, I.F. Charo, C.A. Hebert, R. Horuk, K. Matsushima, L.H. Miller, J.J. Oppenheim and C.A. Power, International union of pharmacology. XXII. Nomenclature for chemokine receptors, Phamacol. Rev. 52 (2000), pp. 145-176.
4. J.Q. Liu and J.R. Merritt, CC chemokine receptor small molecule antagonists in the treatment of rheumatoid arthritis and other siseases: A current view, Curr. Top. Med. Chem. 10 (2010), pp. 1250-1267.
5. R.P. Gladue, M.F. Brown and S.H. Zwillich, CCR1 antagonists: What have we learned from clinical trials, Curr. Top. Med. Chem. 10 (2010), pp. 1268-1277.
6. J.E. Pease and R. Horuk, Chemokine receptor antagonists: Part 1, Expert. Opin. Ther. Pat. 19 (2009), pp. 39-58.
7. J.E. Pease and R. Horuk, Chemokine receptor antagonists: Part 2, Expert. Opin. Ther. Pat. 19 (2009), pp. 199-221.
8. A. Naya, Y. Sagara, K. Ohwaki, T. Saeki, D. Ichikawa, Y. Iwasawa, K. Noguchi and N. Ohtake, Design, synthesis and discovery of a novel CCR1 antagonist, J. Med. Chem. 44 (2001), pp. 1429-1435.
9. A. Naya, M. Ishikawa, K. Matsuda, K. Ohwaki, T. Saeki, K. Noguchi and N. Ohtake, Structure-activity relationships of xanthene carboxamides, novel CCR1 receptor antagonists, Bioorg. Med. Chem. 11 (2003), pp. 875-884.
10. L. Revesz, B. Bollbuck, T. Buhl, J. Eder, R. Esser, R. Feifel, R. Heng, P. Hiestand, B. Jachez-Demange, P. Loetscher, H. Sparrer, A. Schlapbach and R. Waelchli, Novel CCR1 antagonists with oral activity in the mouse collagen induced arthritis, Bioorg. Med. Chem. Lett. 15 (2005), pp. 5160-5164.
11. H.P. Ng, K. May, J.G. Bauman, A. Ghannam, I. Islam, M. Liang, R. Horuk, J. Hesselgesser, R.M. Snider, H.D. Perez and M.M. Morrissey, Discovery of novel non-peptide CCR1 receptor antagonists, J. Med. Chem. 42 (1999), pp. 4680-4694.
12. J.C. Kath, W.H. Brissette, M.F. Brown, M. Conklyn, A.P. Difico, P. Dorff, R.P. Gladue, B.M. Lillie, P.D. Lira, E.N. Mairs, W.H. Martin, E.B. McElroy, M.A. McGlynn, T.J. Paradis, C.S. Poss, I.A. Stock, L.A. Tylaska and D.Y. Zheng, Potent small molecule CCR1 antagonists, Bioorg. Med. Chem. Lett. 14 (2004), pp. 2169-2173.
13. Y.F. Xie, I. Sircar, K. Lake, M. Komandla, K. Ligsay, J. Li, K. Xu, J. Parise, L. Schneider, D.Q. Huang, J.P. Liu, N. Sakurai, M. Barbosa and R. Jack, Identification of novel series of human CCR1 antagonists, Bioorg. Med. Chem. Lett. 18 (2008), pp. 2215-2221.
14. E. Krieger, S.B. Nabuurs and G. Vriend, Homology modeling, Methods Biochem. Anal. 44 (2003), pp. 509-523.
15. A. Patny, P.V. Desai and M.A. Avery, Homology modeling of G-protein-coupled receptors and implications in drug design, Curr. Med. Chem. 13 (2006), pp. 1667-1691.
16. K. Palczewski, T. Kumasaka, T. Hori, C.A. Behnke, H. Motoshima, B.A. Fox, I. Le Trong, D.C. Teller, T. Okada, R.E. Stenkamp, M. Yamamoto and M. Miyano, Crystal structure of rhodopsin: A G protein-coupled receptor, Science 289 (2000), pp. 739-745.
17. V. Cherezov, D.M. Rosenbaum, M.A. Hanson, S.G. Rasmussen, F.S. Thian, T. Kobilka, H.J. Choi, P. Kuhn, W.I. Weis, B.K. Kobilka and R.C. Stevens, High-resolution crystal structure of an engineered human b2-adrenergic G protein-coupled receptor, Science 318 (2007), pp. 1258-1265.
18. V.P. Jaakola, M.T. Griffith, M.A. Hanson, V. Cherezov, E.Y.T. Chien, J.R. Lane, A.P. Ijzerman and R.C. Stevens, The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist, Science 322 (2008), pp. 1211-1217.
19. B.L. Wu, E.Y.T. Chien, C.D. Mol, G. Fenalti, W. Liu, V. Katritch, R. Abagyan, A. Brooun, P. Wells, F.C. Bi, D.J. Hamel, P. Kuhn, T.M. Handel, V. Cherezov and R.C. Stevens, Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists, Science 330 (2010), pp. 1066-1071.
20. E.Y.T. Chien, W. Liu, Q. Zhao, V. Katritch, G.W. Han, M.A. Hanson, L. Shi, A.H. Newman, J.A. Javitch, V. Cherezov and R.C. Stevens, Structure of the human dopamine D3 receptor in complex with a D2/D3 selective antagonist, Science 330 (2010), pp. 1091-1095.
21. G. Li, K.M. Haney, G.E. Kellogg and Y. Zhang, Comparative docking study of anibamine as the first natural product CCR5 antagonist in CCR5 homology models, J. Chem. Inf. Model. 49 (2009), pp. 120-132.
22. B. Kneissl, B. Leonhardt, A. Hildebrandt and S. Tautermann, Revisiting automated G-protein coupled receptor modeling: The benefit of additional template structures for a neurokinin-1 receptor model, J. Med. Chem. 52 (2009), pp. 3166-3173.
23. K. Kanagarajadurai, M. Malini, A. Bhattacharya, M.M. Panicker and R. Sowdhamini, Molecular modeling and docking studies of human 5-hydroxytryptamine 2A (5-HT2A) receptor for the identification of hotspots for ligand binding, Mol. BioSyst. 5 (2009), pp. 1877-1888.
24. F.M. McRobb, B. Capuano, I.T. Crosby, D.K. Chalmers and E. Yuriev, Homology modeling and docking evaluation of aminergic G protein-coupled receptors, J. Chem. Inf. Model. 50 (2010), pp. 626-637.
25. D. Dal Ben, I. Antonini, M. Buccioni, C. Lambertucci, G. Marucci, S. Vittori, R. Volpini and G. Cristalli, Molecular modeling studies on the human neuropeptide S receptor and its antagonists, ChemMedChem. 5 (2010), pp. 371-383.
26. K. Ginalski, Comparative modeling for protein structure prediction, Curr. Opin. Struc. Biol. 16 (2006), pp. 172-177.
27. Z.X. Xiang, Advances in homology protein structure modeling, Curr. Protein Pept. Sc. 7 (2006), pp. 217-227.
28. R. Chenna, H. Sugawara, T. Koike, R. Lopez, T.J. Gibson, D.G. Higgins and J.D. Thompson, Multiple sequence alignment with the Clustal series of programs, Nucleic Acids Res. 31 (2003), pp. 3497-3500.
29. A. Fiser and A. Sali, Modeller: Generation and refinement of homology-based protein structure models, Methods Enzymol. 374 (2003), pp. 461-491.
30. R.A. Laskowski, M.W. MacArthur, D.S. Moss and J.M. Thornton, PROCHECK: A program to check the stereochemical quality of protein structures, J. Appl. Crystallogr. 26 (1993), pp. 283-291.
31. G.M. Morris, D.S. Goodsell, R.S. Halliday, R. Huey, W.E. Hart, R.K. Belew and A.J. Olson, Automated docking using a Lamarckian genetic algorithm and an empirical binding free energy function, J. Comput. Chem. 19 (1998), pp. 1639-1662.
32. L.R. Forrest, C.L. Tang and B. Honig, On the accuracy of homology modeling and sequence alignment methods applied to membrane proteins, Biophys. J. 91 (2006), pp. 508-517.
33. Q.H. Liao, Q.Z. Gao, J. Wei and K.C. Chou, Docking and molecular dynamics study on the inhibitory activity of novel inhibitors on epidermal growth factor receptor (EGFR), Med. Chem. 7 (2011), pp. 24-31.
34. J. Wei, H. Li, W. Qu and Q.Z. Gao, Molecular docking study of A3 adenosine receptor antagonists and pharmacophore-based drug design, Neurochem. Int. 55 (2009), pp. 637-642.
35. M.R. Housaindokht, M.R. Bozorgmehr and M. Bahrololoom, Analysis of ligand binding to proteins using molecular dynamics simulations, J. Theor. Biol. 254 (2008), pp. 294-300.
36. J.F. Wang, D.Q. Wei, L. Li, S.Y. Zheng, Y.X. Li and K.C. Chou, 3D structure modeling of cytochrome P450 2C19 and its implication for personalized drug design, Biochem. Biophy. Res. Co. 355 (2007), pp. 513-519.
37. Y.X. Liu, P. Andre, J. Wei and K. Zhao, 3D-pharmacophere models for CC chemokine receptor 1 antagonists, Med. Chem. 5 (2009), pp. 318-324.
38. F.L. de Mendonca, P.C.A. da Fonseca, R.M. Phillips, J.W. Saldanha, T.J. Williams and J.E. Pease, Site-directed mutagenesis of CC chemokine receptor 1 reveals the mechanism of action of UCB 35625, a small molecule chemokine receptor antagonist, J. Biol. Chem. 280 (2005), pp. 4808-4816.